An Open-Label, Non-Randomized, Multi-Center Phase I Study Evaluating the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Bi-Ligand-drug Conjugate CBP-1018 in Patients with Advanced Solid Tumors.